Minims (Proxymetacaine Hydrochloride)

Proxymetacaine Hydrochloride is used to provide topical ocular anesthesia for procedures involving the anterior segment of the eye.

• Diagnostic eye examinations (tonometry, slit‑lamp): provides rapid surface anesthesia to facilitate accurate measurement and observation.
• Foreign body removal from the cornea or conjunctiva: numbs the ocular surface to allow safe extraction.
• Pre‑operative ocular surface preparation: creates anesthesia before minor surgical interventions such as laser therapy.
• Intra‑ocular pressure measurement procedures: reduces discomfort during applanation tonometry.

• Proxymetacaine Hydrochloride produces local anesthesia by reversibly blocking voltage‑gated sodium channels in peripheral nerve membranes of the ocular surface. This inhibition prevents the initiation and propagation of nerve impulses, thereby eliminating sensation in the cornea and conjunctiva. The effect is rapid, onset within seconds, and is confined to the site of application without systemic absorption. The anesthetic action is localized, lasting several minutes, and dissipates as the drug is cleared from the tear film.

Proxymetacaine Hydrochloride may cause ocular and systemic reactions, most of which are mild and transient.

Common Side Effects

• Stinging or burning sensation upon instillation.
• Temporary blurred vision.
• Redness of the conjunctiva.
• Mild allergic conjunctivitis.
• Eye irritation or discomfort.
• Photophobia (light sensitivity).

Serious or Rare Side Effects

• Corneal epithelial toxicity or ulceration.
• Severe allergic reaction including anaphylaxis.
• Persistent intra‑ocular pressure elevation.
• Vision loss or permanent corneal damage.

When using Proxymetacaine Hydrochloride, several precautions should be observed to ensure safety and effectiveness.

• Assess patient for known hypersensitivity to proxymetacaine or similar anesthetics: avoid use if allergy is present.
• Use only under professional supervision: application should be performed by qualified eye care personnel.
• Avoid administration on eyes with epithelial defects or active infection: may delay healing.
• Do not combine with other topical ocular anesthetics unless directed: risk of additive toxicity.
• Monitor for prolonged anesthesia or visual disturbances: discontinue if symptoms persist.
• Store at room temperature: keep in the original container, protect from light and moisture.

Proxymetacaine Hydrochloride can interact with other ophthalmic agents; awareness of these interactions helps prevent adverse outcomes.

Major Interactions (Avoid)

• Other topical ocular anesthetics: additive neurotoxicity and prolonged corneal numbness.
• Contact lens solutions containing preservatives: increased ocular irritation and epithelial damage.
• Anticholinergic eye drops: may reduce the anesthetic effect on the cornea.

Moderate Interactions (Monitor Closely)

• Topical corticosteroids: may mask signs of infection after anesthesia.
• Beta‑blocker eye drops: monitor intra‑ocular pressure as anesthetic may affect measurements.
• Systemic antihistamines: can exacerbate dryness and discomfort after instillation.